Occidental announced an offer to exercise its outstanding publicly traded warrants at a temporarily reduced price. The Offer is available to ...

The shares of common stock issuable upon exercise of the outstanding warrants are registered pursuant to effective registration statements on Form S-1 (File No. 333-280951) and on Form S-1 (File ...

GT Biopharma, Inc. announced that it has entered into agreements to exercise existing warrants for a total of 302,069 shares of its common stock at an exercise price of $4.35, which were issued in ...

The proceeds from the exercise of the warrants will be used for general working capital purposes, including Firefly’s recently announced strategic initiative to build the world’s first ...

The resale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-1 (File No. 333-280326).

Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody ...

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced an offer to exercise its outstanding ...

In consideration for the immediate exercise of the existing warrants for cash at an exercise price of $2.27 per share, the ...

and no new warrants were issued by the Company as a result of the exercises. The proceeds from the exercise of the warrants will be used for general working capital purposes, including Firefly’s ...

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced an offer to exercise its outstanding publicly traded warrants (the “Warrants”) at a temporarily reduced price ...